Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine)
Produktgrößen
100 ug
£885,00
CHB279-100UG
1 mg
£3375,00
CHB279-1MG
Über dieses Produkt
- SKU:
- CHB279
- Zusätzliche Namen:
- IgG1|Trastuzumab emtansine
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Trastuzumab emtansine is an ADC consisting of a HER2-directed antibody and DM1, a potent derivative of maytansine, used for the study of advanced breast cancer.
- Formulierung:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- ERBB2 / HER2 / CD340
- Isotyp:
- IgG1
- Physischer Zustand:
- Lyophilized
- Reinheit:
- >90%
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Spezifität:
- ERBB2 / HER2 / CD340
- Lagerbedingungen:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:CHB279